LianBio

Public

Princeton, New JerseyBiotechhttps://www.lianbio.com

Last Round

IPO Announced

Oct 31, 2021

Est. Valuation

$1.68B

Total Funding Raised

$635M

Company Overview

LianBio (NAS: LIAN) is a biopharmaceutical company focused on developing and commercializing innovative medicines for patients with unmet medical needs, primarily through in-licensing assets for Greater China and other Asian markets, while advancing a diverse portfolio of clinically validated product candidates across various therapeutic areas including cardiovascular, oncology, ophthalmology, inflammatory disease, and respiratory indications.

Sector

Biotech

AI Layer

Non-AI

Keywords

pharmaceutical in-licensing for Asian marketscross-border drug development platformlate-stage clinical asset developmentChina drug commercialization strategybiopharma market access for Chinaclinical trial management in ChinaNMPA regulatory approval navigationpharmaceutical asset monetizationoncology drug development for Asiacardiovascular disease drug developmentophthalmology therapeutic pipeline

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

LianBio Comps

Public and private peers based on sector, stage, and business model.

Company	Status	Est. Valuation	Rev Multiple
OpenAI	Private	$86.0B	~40x
Cohere	Private	$5.0B	--
Competitor 1	Public	$XX.XB	XXx
Competitor 2	Public	$XX.XB	XXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

LianBio Funding Rounds

Historical fundraising activity

Round	Date	Amount Raised	Valuation	Investors	Sources
IPO Announced	Oct 31, 2021
Series A	Oct 29, 2020
Seed	Aug 11, 2020

View all Funding Rounds

LianBio Investors

Notable investors and investment history

Investor	Rounds
RA Capital Management	Series A
Farallon Capital Management	Series A
Perceptive Advisors	Series A, Seed
Vida Ventures	Series A
Travilah Consulting Group	Series A
Tybourne Capital Management	Series A
Logos Capital	Series A

View all Investors

LianBio Filings

SEC and related filings with document metadata.

Typed	Date	Amount Offered	Amount Sold	Filling	Pages	Download
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation

LianBio Filings

SEC and related filings with document metadata.

Firmographic Details

HeadquartersPrinceton, New Jersey

Employee Range46

Year Founded1999

Last FundingOct 31, 2021

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.